Copernicus Capital Management as of June 30, 2020
Portfolio Holdings for Copernicus Capital Management
Copernicus Capital Management holds 18 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 11.8 | $11M | 110k | 98.18 | |
| Bristol Myers Squibb (BMY) | 11.1 | $10M | 172k | 58.80 | |
| Alexion Pharmaceuticals | 10.5 | $9.5M | 85k | 112.24 | |
| Amgen (AMGN) | 8.5 | $7.8M | 33k | 235.85 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 7.1 | $6.5M | 22k | 290.29 | |
| BioMarin Pharmaceutical (BMRN) | 6.7 | $6.2M | 50k | 123.33 | |
| Iqvia Holdings (IQV) | 6.2 | $5.7M | 40k | 141.88 | |
| Myokardia | 6.0 | $5.5M | 57k | 96.61 | |
| Fate Therapeutics (FATE) | 5.8 | $5.3M | 156k | 34.31 | |
| Arena Pharmaceuticals Com New | 5.5 | $5.0M | 80k | 62.95 | |
| Horizon Therapeutics Pub SHS | 5.2 | $4.7M | 85k | 55.59 | |
| Arcus Biosciences Incorporated (RCUS) | 3.4 | $3.1M | 124k | 24.74 | |
| Momenta Pharmaceuticals | 3.2 | $2.9M | 88k | 33.27 | |
| Gw Pharmaceuticals Ads | 3.0 | $2.7M | 22k | 122.73 | |
| Eiger Biopharmaceuticals | 2.1 | $1.9M | 200k | 9.60 | |
| Translate Bio | 1.8 | $1.6M | 90k | 17.92 | |
| Cymabay Therapeutics | 1.1 | $1.0M | 287k | 3.49 | |
| OraSure Technologies (OSUR) | 1.0 | $917k | 79k | 11.63 |
